Research

SPS3

Sponsor: NIH

Purpose

The goal of this study is to learn if combination therapy (aspirin and clopidogrel) is more effective than aspirin alone for prevention of recurrent stroke in cognition, and if intensive blood pressure control is associated with fewer recurrent strokes and reduction in cognition.

This study is currently enrolling.

Principal Investigator: Sunita Santhakumar, MD

Contact Flicia Mada, RN at (313) 745-1893 for more information.

TIMI 50

Sponsor: Schering-Plough

Purpose

The study is designed to determine whether SCH 530348, when added to the existing standard of care for preventing heart attack and stroke (eg., aspirin, clopidogrel) in patients with a known history of atherosclerosis, will yield additional benefit over the existing standard of care without SCH 530348 in preventing heart attack and stroke.